Category: Uncategorized

THE NEED FOR A COLD CHAIN FOR DEVELOPING COUNTRIES VACCINES is a significant obstacle for healthcare initiatives. It also contributes about 80% of the cost. Remember that Next Generation DNA VACCINES do not require a cold chain, and can be delivered nasally, making delivery significantly less challenging. View in LinkedIn

0 View in LinkedIn

0 View in LinkedIn

THE CRISIS IS PERHAPS THE BEST REASON TO INVEST IN EARLY STAGE COMPANIES as Japan telecom and Softbank have just demonstrated. The assumption is that these young companies will generate new wealth and jobs and help nations grow out of economic depression. View in LinkedIn

0 View in LinkedIn

DESPITE JAPAN'S ECONOMIC CLIMATE, FOSTERING STARTUPS IS HIGH ON THE PRIORITY LIST. http://www.redherring.com/features/staff-picks/softbank-launches-250m-fund-to-help-startups-asian-expansion/ View in LinkedIn

0 http://www.manufacturingchemist.com/news/article_page/Biopharma_innovation_on_the_rise_in_emerging_countries_report_finds/81810 View in LinkedIn

GREECE'S MENTOR NETWORK GIVES A BOOST TO EARLY STAGE COMPANIES: IF THEY CAN, SO CAN OTHERS. In the midst of the Crisis meltdown, Greek entrepreneurial heavyweights show they can assist the future economic engine of their economy. A template for other countries, just as Israel has done with great success. View in LinkedIn

EUROPE NEEDS MORE VENTURE FIRMS AND EARLY STAGE CAPITAL TO COMPETE WITH THE US which has run at 5X the EC level of investment for years, along with higher valuations. Either the EC must bite the bullet and either incentivize capital investment in early stage companies, or set aside funds to make public-private investments at a higher level. View in LinkedIn

A GOOD SOURCE FOR RECENT FUNDING UPDATES. View in LinkedIn